In the June Matters in Managed Care webinar, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed discussed how they are working together to address some of the state’s unique primary care needs.
The COVID-19 pandemic magnified the crucial role of primary care in advancing population health. Payers and providers are collaborating in novel ways to expand access to quality, affordable primary care.
In the latest Matters in Managed Care webinar from The American Journal of Managed Care®(AJMC)®, experts from Blue Cross and Blue Shield of North Carolina, Duke-Margolis Center for Health Policy, UNC Center for the Business of Health, and WakeMed sat down to discuss how payers and primary care providers are managing patient needs during this time of pandemic change, including efforts to expand access to value-based care and connect behavioral/mental health, health equity, and primary care.
Brian Klausner, MD, medical director, Community Population Health at WakeMed Primary Care, moderated the June 2021 discussion with Devdutta Sangvai, MD, MBA, vice president, Population Health Management, Duke University Health System; Leslie McKinney, MD, FACEP, senior medical director, Blue Cross NC Advanced Primary Care and Value-Based Provider Engagement; and Rivers Woodward, MD, MBA, family physician, and Blue Ridge Community Health Services.
In part 6, the panel discusses how issues regarding health equity have manifested over the past year.
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More